Telo Genomics Corp Stock Technical Analysis
| TDSGF Stock | USD 0.04 0.01 15.62% |
As of the 15th of February 2026, Telo Genomics has the Semi Deviation of 7.15, risk adjusted performance of 0.0274, and Coefficient Of Variation of 4405.98. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Telo Genomics Corp, as well as the relationship between them. In other words, you can use this information to find out if the company will indeed mirror its model of past prices and volume data, or the prices will eventually revert. We were able to analyze and collect data for nineteen technical drivers for Telo Genomics Corp, which can be compared to its competition. Please validate Telo Genomics Corp treynor ratio, as well as the relationship between the downside variance and kurtosis to decide if Telo Genomics is priced more or less accurately, providing market reflects its prevalent price of 0.037 per share. As Telo Genomics Corp appears to be a penny stock we also recommend to double-check its total risk alpha numbers.
Telo Genomics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Telo, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to TeloTelo |
Telo Genomics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Telo Genomics' otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Telo Genomics.
| 11/17/2025 |
| 02/15/2026 |
If you would invest 0.00 in Telo Genomics on November 17, 2025 and sell it all today you would earn a total of 0.00 from holding Telo Genomics Corp or generate 0.0% return on investment in Telo Genomics over 90 days. Telo Genomics is related to or competes with Interpace Biosciences, and Healthlynked Corp. Telo Genomics Corp., a biotech company, engages in the development and commercialization of predictive technological pro... More
Telo Genomics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Telo Genomics' otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Telo Genomics Corp upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 18.27 | |||
| Information Ratio | 0.0146 | |||
| Maximum Drawdown | 48.57 | |||
| Value At Risk | (15.00) | |||
| Potential Upside | 15.63 |
Telo Genomics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Telo Genomics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Telo Genomics' standard deviation. In reality, there are many statistical measures that can use Telo Genomics historical prices to predict the future Telo Genomics' volatility.| Risk Adjusted Performance | 0.0274 | |||
| Jensen Alpha | 0.1159 | |||
| Total Risk Alpha | (0.45) | |||
| Sortino Ratio | 0.0069 | |||
| Treynor Ratio | 0.1596 |
Telo Genomics February 15, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0274 | |||
| Market Risk Adjusted Performance | 0.1696 | |||
| Mean Deviation | 4.51 | |||
| Semi Deviation | 7.15 | |||
| Downside Deviation | 18.27 | |||
| Coefficient Of Variation | 4405.98 | |||
| Standard Deviation | 8.62 | |||
| Variance | 74.24 | |||
| Information Ratio | 0.0146 | |||
| Jensen Alpha | 0.1159 | |||
| Total Risk Alpha | (0.45) | |||
| Sortino Ratio | 0.0069 | |||
| Treynor Ratio | 0.1596 | |||
| Maximum Drawdown | 48.57 | |||
| Value At Risk | (15.00) | |||
| Potential Upside | 15.63 | |||
| Downside Variance | 333.83 | |||
| Semi Variance | 51.16 | |||
| Expected Short fall | (11.65) | |||
| Skewness | (0.71) | |||
| Kurtosis | 3.15 |
Telo Genomics Corp Backtested Returns
Telo Genomics Corp owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0221, which indicates the firm had a -0.0221 % return per unit of risk over the last 3 months. Telo Genomics Corp exposes twenty-seven different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Telo Genomics' Risk Adjusted Performance of 0.0274, semi deviation of 7.15, and Coefficient Of Variation of 4405.98 to confirm the risk estimate we provide. The entity has a beta of 1.16, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Telo Genomics will likely underperform. At this point, Telo Genomics Corp has a negative expected return of -0.19%. Please make sure to validate Telo Genomics' treynor ratio and the relationship between the downside variance and day typical price , to decide if Telo Genomics Corp performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.10 |
Insignificant predictability
Telo Genomics Corp has insignificant predictability. Overlapping area represents the amount of predictability between Telo Genomics time series from 17th of November 2025 to 1st of January 2026 and 1st of January 2026 to 15th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Telo Genomics Corp price movement. The serial correlation of 0.1 indicates that less than 10.0% of current Telo Genomics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.1 | |
| Spearman Rank Test | -0.26 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Telo Genomics technical otc stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, otc market cycles, or different charting patterns.
Telo Genomics Corp Technical Analysis
The output start index for this execution was one with a total number of output elements of sixty. The Normalized Average True Range is used to analyze tradable apportunities for Telo Genomics Corp across different markets.
About Telo Genomics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Telo Genomics Corp on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Telo Genomics Corp based on its technical analysis. In general, a bottom-up approach, as applied to this otc stock, focuses on Telo Genomics Corp price pattern first instead of the macroeconomic environment surrounding Telo Genomics Corp. By analyzing Telo Genomics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Telo Genomics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Telo Genomics specific price patterns or momentum indicators. Please read more on our technical analysis page.
Telo Genomics February 15, 2026 Technical Indicators
Most technical analysis of Telo help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Telo from various momentum indicators to cycle indicators. When you analyze Telo charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0274 | |||
| Market Risk Adjusted Performance | 0.1696 | |||
| Mean Deviation | 4.51 | |||
| Semi Deviation | 7.15 | |||
| Downside Deviation | 18.27 | |||
| Coefficient Of Variation | 4405.98 | |||
| Standard Deviation | 8.62 | |||
| Variance | 74.24 | |||
| Information Ratio | 0.0146 | |||
| Jensen Alpha | 0.1159 | |||
| Total Risk Alpha | (0.45) | |||
| Sortino Ratio | 0.0069 | |||
| Treynor Ratio | 0.1596 | |||
| Maximum Drawdown | 48.57 | |||
| Value At Risk | (15.00) | |||
| Potential Upside | 15.63 | |||
| Downside Variance | 333.83 | |||
| Semi Variance | 51.16 | |||
| Expected Short fall | (11.65) | |||
| Skewness | (0.71) | |||
| Kurtosis | 3.15 |
Telo Genomics February 15, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Telo stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.00 | ||
| Daily Balance Of Power | Huge | ||
| Rate Of Daily Change | 1.16 | ||
| Day Median Price | 0.04 | ||
| Day Typical Price | 0.04 | ||
| Price Action Indicator | 0.00 |
Complementary Tools for Telo OTC Stock analysis
When running Telo Genomics' price analysis, check to measure Telo Genomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Telo Genomics is operating at the current time. Most of Telo Genomics' value examination focuses on studying past and present price action to predict the probability of Telo Genomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Telo Genomics' price. Additionally, you may evaluate how the addition of Telo Genomics to your portfolios can decrease your overall portfolio volatility.
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |